Skye Bioscience SKYE
NASDAQ SKYE
$1.54 -0.08 (-4.94%)
At close: Oct 23, 2026 · 4:00 PM EDT

Skye Bioscience (SKYE) Purchase of Investments (2025)

Updated

Analysis

Skye Bioscience (SKYE) Purchase of Investments (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Purchased (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 307.00 Mn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 919.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 834.00 Mn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 148.00 Mn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 46.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 42.00 Mn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.54 Bn
10 Skye Bioscience 6.77 Mn -81.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 2.98 Mn
Sep 30, 2025 -7.88 Mn
Jun 30, 2025 11.94 Mn
Mar 31, 2025 12.80 Mn
API Access

Skye Bioscience Purchase of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=purchase-of-investments&ticker=SKYE&period=max&api_key=YOUR_API_KEY